The molecular biology and therapeutic potential of Nrf2 in leukemia
Atefeh Khodakarami(Tabriz University of Medical Sciences), Farhad Jadidi-Niaragh(Tabriz University of Medical Sciences), Hamed Mohammadi(Tehran University of Medical Sciences), Sara Adibfar(Kermanshah University of Medical Sciences), Jamshid Gholizadeh Navashenaq(Bam University of Medical Sciences), Shiva Abolhasani(Tabriz University of Medical Sciences), Mohammad Hojjat‐Farsangi(Karolinska University Hospital), Vahid Karpisheh(Tabriz University of Medical Sciences), Pooya Jalali(Tabriz University of Medical Sciences)
Cited by 46
Related Papers
Nanoparticles and targeted drug delivery in cancer therapy
|Immunology Letters|2017|507
The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer
|Biomedicine & Pharmacotherapy|2018|312
The paradox of Th17 cell functions in tumor immunity
|Cellular Immunology|2017|222
Small-Molecule Inhibitors of the Receptor Tyrosine Kinases: Promising Tools for Targeted Cancer Therapies
|International Journal of Molecular Sciences|2014|202
CDK1 in Breast Cancer: Implications for Theranostic Potential
|Anti-Cancer Agents in Medicinal Chemistry|2020|169